These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3085244)
21. [Incidence of hepatitis B in hemophilia patients]. Thoms J; Berles R; Syrbe G Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):523-9. PubMed ID: 2446993 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies]. Gassmann AE; Kerkhofs H; Leeksma CH Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542 [No Abstract] [Full Text] [Related]
28. [Hepatitis-associated antigen and antibodies after multiple transfusions in children and juveniles with severe and moderately severe haemophilia (author's transl)]. Schwartz B; Landbeck G Dtsch Med Wochenschr; 1973 Oct; 98(43):2016-9. PubMed ID: 4744372 [No Abstract] [Full Text] [Related]
29. A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentrates. Aznar JA; Carbonell F; Jorquera JI; Carmona E; Sánchez-Cuenca JM; Trénor A; de Andrés-Medina R; González-Molina A Ric Clin Lab; 1985; 15(4):315-21. PubMed ID: 3938863 [TBL] [Abstract][Full Text] [Related]
30. Prophylaxis and complications in hemophilia. Introductory remarks. Harris CE Bibl Haematol; 1970; 34():97-103. PubMed ID: 5436358 [No Abstract] [Full Text] [Related]
31. [Analysis of various adverse effects of substitute treatment of children with hemophilia]. Adamowicz-Salach A; Głoskowska-Moraczewska Z; Klukowska A; Kamińska D Pediatr Pol; 1988 May; 63(5):326-31. PubMed ID: 2851128 [No Abstract] [Full Text] [Related]
32. [The appearance of anti-thrombocyte and anti-leukocyte antibodies in hemophilia A patients after cryoprecipitate transfusions]. Uteg KH; Májský A Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(5):771-6. PubMed ID: 64419 [TBL] [Abstract][Full Text] [Related]
33. HIV, HBV and HCV seropositivity in hemophiliacs. Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):339-44. PubMed ID: 1726973 [TBL] [Abstract][Full Text] [Related]
34. Immune status of blood product recipients. Jason J; Hilgartner M; Holman RC; Dixon G; Spira TJ; Aledort L; Evatt B JAMA; 1985 Feb; 253(8):1140-5. PubMed ID: 3918187 [TBL] [Abstract][Full Text] [Related]
35. Hemophilia, hepatitis and HAA. Lewis JH Vox Sang; 1970; 19(3):406-9. PubMed ID: 5502767 [No Abstract] [Full Text] [Related]
37. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)]. Kamiya T Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775 [No Abstract] [Full Text] [Related]
38. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia. McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730 [TBL] [Abstract][Full Text] [Related]
39. Jaundice and hepatitis B antigen-antibody in hemophilia. Lewis JH; Maxwell NG; Brandon JM Transfusion; 1974; 14(3):203-11. PubMed ID: 4835949 [No Abstract] [Full Text] [Related]
40. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household]. Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]